Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of IV Oxycodone for Hemodynamic Attenuation During Intubation
NCT02484352Phase 4Completed
- Start
- Jul 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone. Started Jul 2015; status: completed.
02
Drugs
oxycodone
Beyond the preview
Go deeper on NCT02484352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484352.